Sotorasib and Panitumumab Versus Investigator's Choice for Participants With Kirsten Rat Sarcoma (KRAS) p.G12C Mutation

Clinical trial NCT05198934 · COMPLETED

Trial details

NCT number: NCT05198934
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Colorectal Cancer (CRC)

Start date: 2022-04-19
Primary completion: 2025-07-16
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.